Skip to ContentSkip to Navigation
Practical matters How to find us A.G.H. Niezink


Durvalumab increases the risk of radiation pneumonitis in non-small-cell lung cancer patients

First clinical experiences in treating oesophageal cancer with intensity-modulated proton therapy

Proton therapy in mediastinal lymphoma patients in a nationwide cohort, using model-based selection

A multivariable prediction model for severe toxicity after chemoradiation for esophageal cancer

Extranodal Natural Killer/T-cell Lymphoma, Nasal Type: Diagnosis and Treatment

Fraction Delta NTCP calculation using automatic 4D accumulated dose in IMPT for thoracic indications

Hematologische ziektebeelden

Introducing IMPT for mediastinal lymphoma: feasibility and NTCP model based selection of patients

Introduction of IMPT for (N)SCLC patients: NTCP model based selection of patients and first results

Nieuwe hoop voor patiënten met uitbehandelde lymfeklierkanker: CD19-gerichte CAR-T-celtherapie

Read more